Norvik Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Bangalore, Karnataka, India, established in 2004.

2004 Bangalore, Karnataka, India Active

Last Updated: December 22, 2025

About Norvik Pharmaceuticals Private Limited

Norvik Pharmaceuticals Private Limited, a active private limited company, was established on 16 January 2004 in Bangalore, Karnataka, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231KA2004PTC033198. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Suma Kishore (Director), Prema Kumari Munegowda (Director). Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at No.2115Norvikvillad-Block,Sahakarnagar,, Bangalore, Karnataka, 560092.

Company Details

CIN/LLPIN
U24231KA2004PTC033198
Registration Number
033198
Incorporation Date
16 January 2004
Authorized Capital
₹0.50 M
Paid-Up Capital
₹0.10 M
ROC Code
Roc Bangalore
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 0.50 M as on 22-12-2025
Paid Up Capital ₹ 0.10 M as on 22-12-2025
Company Age 22 Year, 24 Days
Last Filing with ROC 31 Mar 2020
Revenue Growth **** 14.70% (FY 2020)
Profit Growth **** 3.30% (FY 2020)
Ebitda **** -29.63% (FY 2020)
Net Worth -90.61% (FY 2020)
Total Assets **** 153.72% (FY 2020)

Comprehensive Company Insights

Explore comprehensive insights into Norvik Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Norvik Pharmaceuticals Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Suma Kishore	Director	16 Jan 2004	Current
Prema Kumari Munegowda	Director	16 Jan 2004	Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Norvik Pharmaceuticals.

Norvik Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 14.7% increase. The company also saw a slight improvement in profitability, with a 3.3% increase in profit. The company's net worth observed a substantial decline by a decrease of 90.61%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

14.70%

*******

Revenue from Operations

*******

10.01%

*******

Total Assets

*******

153.72%

*******

Profit or Loss

*******

3.30%

*******

Net Worth

*******

-90.61%

*******

EBITDA

*******

-29.63%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Norvik Pharmaceuticals?

In 2020, Norvik Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Norvik Pharmaceuticals?

Unlock and access historical data on people associated with Norvik Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Norvik Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Norvik Pharmaceuticals's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Norvik Pharmaceuticals

Recent Activity within the Organization

Annual General Meeting

The activity Norvik Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was completed.
31 Dec 2020
Balance Sheet

The activity Norvik Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Bangalore. was completed.
31 Mar 2020
Director Appointment

Suma Kishore was appointed as a Director was appointed as a Director on 16 Jan 2004 & has been associated with this company since 22 years 24 days . was recorded as a recent event.
16 Jan 2004
Director Appointment

Progress on Prema Kumari Munegowda was appointed as a Director was appointed as a Director on 16 Jan 2004 & has been associated with this company since 22 years 24 days . was documented.
16 Jan 2004
Company Incorporation

Progress on Norvik Pharmaceuticals Private Limited was registered on 16 Jan 2004 with Roc Bangalore & aged 22 years 24 days as per MCA records. was documented.
16 Jan 2004

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Norvik Pharmaceuticals Private Limited?

The CIN of Norvik Pharmaceuticals Private Limited is U24231KA2004PTC033198.

Where is Norvik Pharmaceuticals Private Limited headquartered?

Norvik Pharmaceuticals Private Limited is headquartered at No.2115Norvikvillad-Block,Sahakarnagar,, Bangalore, Karnataka, 560092.

When was Norvik Pharmaceuticals Private Limited incorporated?

Norvik Pharmaceuticals Private Limited was incorporated on 16 January 2004.

Who are the current directors of Norvik Pharmaceuticals Private Limited?

The current directors of Norvik Pharmaceuticals Private Limited are

What is the primary industry of Norvik Pharmaceuticals Private Limited?

The primary industry of Norvik Pharmaceuticals Private Limited is Trade.

Is Norvik Pharmaceuticals Private Limited a listed company?

Norvik Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Norvik Pharmaceuticals Private Limited?

The authorized capital of Norvik Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Norvik Pharmaceuticals Private Limited?

The compliance status of Norvik Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available